SCS goes green
Wednesday, 18 June, 2008
Stem Cell Sciences (ASX: STC) will license a green florescent protein (GFP) technology from US-based Prolume, the company announced today.
GFP can be used to tag certain cells and follow their development. It can, for example, be used by stem cell cultivators to isolate cells which have developed from particularly enriched stem cells.
The financial terms of the deal have not been disclosed.
The GFP technology will be added to SCS's Proven research reagents portfolio and to some of its stem cell-related technologies.
Multiple myeloma treatment reprograms patients' own immune cells
An Australian and Victorian Government funding agreement has allowed eligible Australians with...
Could 'fusion proteins' reduce errors in a promising gene-editing tool?
Gene-editing tool CRISPR-Cas9 is used, among many things, to engineer new cancer immunotherapies....
Cancer research and clinical trials at the core of new centre
The Australian Cancer Research Foundation Centre for Dynamic Immuno-Oncology (CDIO) has been...
